UnknownPhase 3

Curative Effect and Quality of Life Between Uniportal and Open Sleeve Lobectomy for Central Type Lung Cancer

China200 participantsStarted 2018-05-15

Plain-language summary

In surgical treatment decisions, locally advanced central lung cancer is the most difficult. When infiltrating into the trachea, conventional pneumonectomy cannot achieve the purpose of radical treatment.Pulmonary sleeve resection involves the removal of part of the main bronchus and can completely remove the tumor, as far as possible to retain normal lung function, fully embodies the surgical principle and is worthy of clinical promotion.this study intends to compare uniportal-sleeve and open-chest sleeve lobectomy for the treatment of central lung cancer, analyzing the curative effect and quality of life of postoperative patients on the basis of previous accumulation.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The tumor is located in the opening of bronchus, or the edge of the tumor is \<2 cm away from the opening of the bronchi;
✓. The distance between the edge of the tumor and the carina is \>1.5 cm;
✓. Partial benign lesions or the presence of bronchial stenosis Patient.

Exclusion criteria

✕. Distant metastasis;
✕. Cardiopulmonary function cannot tolerate surgery.

What they're measuring

Postoperative pain

Timeframe: 6 months

Quality of life

Timeframe: 6 months

Trial details

NCT IDNCT03523468

SponsorLei Jiang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-30

View on ClinicalTrials.gov More Video-Assisted Thoracic Surgery trials